A B S T R A C T Our recent in vivo studies have suggested that intrapituitary L-thyroxine (T4) to 3,5,3'-triiodo-L-thyronine (T3) conversion with subsequent nuclear binding of T3 is an important pathway by which circulating T4 R. In fasted rats, neither N:M ratio was depressed, although hepatic T4 to T3 conversion in the same animals was 50% of control (P < 0.005). lopanoic acid (13 ,uM), but not 6-n-propylthiouracil (29 MM), decreased the N:M ['251]T3 with a significant decrease in the value for R (P < 0.025 or less). Neither sodium iodide (6 ,uM) nor thyrotropin-releasing hormone (7-700 nM) affected the T3 N:M ratios. These results indicate that intrapituitary T4 to T3 conversion is stimulated in hypothyroidism and depressed in T4-treated animals, whereas opposite changes occur in hepatic T4-5'-monodeiodination. Unlike liver, anterior pituitary T4-5'-monodeiodination is not affected by fasting or incubation with 6-n-propyl-2-thiouracil, but T4 to T3 conversion is inhibited in both by iopanoic acid. These results indicate that there are important differences between anterior pituitary and other tissues in the regulation of T4-5'-monodeiodination.
A B S T R A C T Our recent in vivo studies have suggested that intrapituitary L-thyroxine (T4) to 3,5,3'-triiodo-L-thyronine (T3) conversion with subsequent nuclear binding of T3 is an important pathway by which circulating T4 can inhibit thyrotropin release. The present studies were performed to evaluate various physiological and pharmacological influences on these two processes in rat anterior pituitary tissue. Intact pituitary fragments were incubated in buffer-1% bovine serum albumin containing 0.14 ng/ml [131I]T3 and 3. 8 (mean ± SD, n = 51). A ratio (R), the N: M [1251]T3 divided by the N:M [13lI]T3, was used as an index of intrapituitary T4 to T3 conversion. Increasing medium T3 concentrations up to 50 ng/ml caused a progressive decrease in the N:M ratio for both T3 isotopes, but no change in the value for R, indicating that both competed for the same limited-capacity nuclear receptors. In-
INTRODUCTION
Recent in vivo studies from our laboratory have demonstrated a quantitative and chronological re-by 3,5,3'-triiodo-L-thyronine (T3)1 and the acute suppression of thyrotropin (TSH) release in hypothyroid rats (1, 2) . Moreover, the acute TSH suppression observed after infusion of L-thyroxine (T4) was accompanied by intrapituitary conversion of T4 to T3 that was so rapid, virtually all of the acute effect of T4 on suppression of TSH release could be explained on the basis of the T3 produced (1, 2) . In more recent studies, we have demonstrated that in the euthyroid rat, -50% of specifically bound pituitary nuclear T3 derives from plasma T3, and the remaining 50% appears to originate from intrapituitary T4 to T3 conversion (3). The total saturation of available nuclear T3 receptors in the euthyroid rat anterior pituitary was estimated to be 78%, a saturation significantly higher than that of hepatic and kidney nuclear T3 receptors in the same animals (_50%) (3). This provides a possible explanation for the increased secretion of TSH in response to a decrease in plasma T4 concentration even when plasma T3 remains constant. This combination of developments is often observed in patients in the early phases of thyroid gland failure and in those with endemic goiter. If this hypothesis is correct, then the regulation of intrapituitary T4 to T3 conversion and control ofthe binding ofthe T3 produced to the specific nuclear thyroid hormone receptor constitute an important means for modulation of the thyroid hormone feedback on the pituitary thyrothroph. The following studies were undertaken to evaluate the uptake of T4, its conversion to T3, and the subse(quent nuclear binding of the T3 produced in anterior pituitary tissue in vitro. In a recent preliminary report, we have described the in vitro system used in the present study and provided data indicating that in vitro T4 to T3 conversion is readily detectable using this method (4).
METHODS
Preparation and incubation of pituitary tissue. Anterior pituitaries from 300 to 450-g male, Sprague-Dawley rats (ZivicMiller Laboratories, Allison Park, Pa.) were removed, cut into quarters, and incubated in modified Gey and Gey buffer containing 1 mg/ml D-glucose, and 10 mg/ml bovine serum albumin (BSA) as previously described (4). About 30 min preincubation time was required for the collection and randomization of tissue fragments. The 400-,ul incubation volume contained 5-11 mg anterior pituitary tissue, 2,uCi of ['25I]T4 (specific activity 1,200-1,400 ,uCi/,g), and 0.2 ,uCi ['311 ]T3 (specific activity 3,500,Ci/ug). The gravimetric iodothyronine concentrations were -3.8 ng T4/ml and 0.14 ng T3/ml, based on these specific activities, except where otherwise specified. The free fraction of T4 in the 1% BSA-buffer solution was 0.32±0.02% (mean+SE) and the ' Abbreviations used in this paper: BSA, bovine serum albumin; N:M, nuclear medium ratio; PTU, 6-n-propyl-2-thiouracil; R, N:M T3(T4) N:M T3(T3); T3, 3,5,3'-triiodo-L-thyronine; T4, L-thyroxine; TRH, thyrotropin-releasing hormone; TSH, thyrotropin. free fraction of T3 was 2.3±0.15% as determined by equilibrium dialysis (5) . Neither free fraction was altered in the presence of 50 ng/ml T3 or 75 ng/ml T4.
Isolation of nuclei, identification of isotopes, and calculations. After a customary 3-h incubation at 37°C, the pituitary fragments were homogenized in 2.5 ml 0.3 M sucrose/1.1 mM MgCl2 in a glass homogenizer and nuclei were isolated by centrifugation at 1,000 g. Nuclei were washed twice in 2.5 ml sucrose-MgCl2 containing 0.5% Triton X-100 (Rohm and Haas Co., Philadelphia, Pa.) and once in 2.5 ml 0.15 M NaCl. Tubes were kept at 4°C throughout. In early studies, nuclear iodothyronines were extracted in 2 ml butanol:2 N HCl (9:1) (37°C for 30 min). The acid:butanol was dried under N2 at 37°C and redissolved in 100 ,lM of ethanol:concentrated NH40H (99:1), which contained 100 ,ug of T3, T4, and Nal. These ethanol extracts were applied directly to Whatman 3 MM chromatography strips (Fisher Scientific Co., Pittsburgh, Pa.), which were then developed for 24 h in tertiary amyl alcohol:hexane:NH40H as previously described (4, 6). This procedure does not result in the formation of the butyl ester of T4 as shown by control studies performed with ['251]T4 added to isolated nuclei. In later experiments (about two-thirds of those reported here), the acid-butanol step was omitted, and the nuclear iodothyronines were extracted directly into the ethanol:NH40H-containing T3, T4, and NaL. (6) . In some experiments (Table I) , ['25I]T3 and ['31I]T3 were identified in the extranuclear fractions by adding 1.8 ml of the 2.5 ml supernate of the first 1000 g centrifugation to the T3 antibody-Sepharose (Pharmacia Fine Chemicals, Piscataway, N. J.) conjugate (7) . After overnight incubation, the conjugates were washed as previously described, and the labeled hormones were eluted in MeOH:2 N NH40H (99:1, vol/vol) and chromatographed as described above (7) . The chromatographs of nuclear and extranuclear fractions were counted at the same time to facilitate calculation of the nuclear:extranuclear ratio for each T3 isotope.
The Table I are shown data indicating that there is no alteration in the extranuclear (cytosol):medium ratio for [3l1I]T3 resulting from increasing the medium T3 concentration to as high as 1,000 ng/ml. This indicates that there is no saturation of T3 transport into the cytosol at the concentrations of T3 used in these studies. Therefore, the reduction in the nuclear:extranuclear ratio for ["3lI]T3 found when the medium T3 concentration is increased from 0.14 to 12.5 ng/ml (right-hand portion of is specifically bound to limited-capacity nuclear binding sites, whereas the binding of T4 in this system is largely nonspecific. In the lower portion of Table I is shown the effect of increasing concentrations of medium T3 on the same parameters. As before, the quan- T4 that is "non-specifically" bound, it was not possible to determine whether there was specifically bound nuclear T4 in this system, and this will not be discussed further. To calculate specifically bound nuclear T3, nonspecifically bound T3 should be deducted from the total. However, because this was <10% of that bound in the presence of 0.14 ng T3/ml (Table II) In Table III are presented studies of the relationship between the duration of incubation and the N:M ratios for T3(T3) and T3(T4). In experiment A the N:M ratio for T3(T3) increases rapidly to an apparent plateau by 4 h. However, in experiments B and C there was a further increase of 25-50% in the N:M T3(T3) ratio over the subsequent 3-to 5-h period. The N:M ratio of T3(T4) showed a somewhat different pattern. In experiment A this ratio was not significantly different from that for T3(T3) until 2 h of incubation, and the ratio continued to increase up to the 4th h. The increase in the N:M T3(T4) relative to the N:M (T3(T3) is reflected in a rising value for R. In experiments B and C there were further increases in R with longer incubations up to 8 h. We attempted to evaluate the effects of incubation for longer periods, but the tissue did not Effects of altering concentrations of medium iodothyronines on N:M ratios for T3(T) and T3(T4). Results of studies of the effects of increasing concentrations of medium iodothyronines are shown in Tables IV and V. Since the specific nuclear receptor sites have limited binding capacity for T3 in vivo and in vitro (Table II) , one would anticipate that increasing medium T3 concentrations would lead to decreases in both N:M (T3(T3) and N:M T3(T4) if these two species are competing for the same nuclear receptor site. This prediction is borne out in the experiments shown in Table IV . A significant reduction in the N:M T3(T3) and N:M T3(T4) was achieved in experiment A at 2.5 ng T3/ml and in experiments C and D at 12.5 ng T3/ml. Although there are also apparent decreases in both N:M ratios in experiments B and E, these differences did not achieve statistical significance in the triplicate samples. In no experiment was the R value different from that at the lowest T3 concentration of 0.14 ng T3/ml.
RESULTS

Methodological considerations. In
The effects of increasing medium T4 concentrations were considerably different (Table V) . In none of the four experiments were significant differences found in the N:M T3(T3) ratio with medium T4 concentrations up to 75 ng/ml. Changes in the N:M ratio for T3(T4) were also not significant at any of these T4 coincenitrations. However, there was a numerical decrease in the N:M T3(T4) at the highest concentration of T4 used in all experiments. This change is reflected in a decrease in the value for R that was statistically significant in three of the four experiments. These results suggest that there is saturation of the pathway for generating nuclear T3(T4) before saturation of the nuclear receptor sites by the T3 present in the T4 or by that generated from it. The more ready saturation ofthe nuclear receptors with T3, as opposed to T4, is reflected in the fact that there is little, if any, decrease in the N:M T3(T3) at medium T4 concentrations which are fiveand sixfold in excess of those at which a T3 effect was usually observed.
Effects of alterations in thyroid status onl pituitary T4 5'-monodeiodination and nuclear binding. Hypothyroidism has been shown to reduce and T4 administration to increase, the rate of 5'-monodeiodination in rat liver (16) . To examine the effects of altered thyroid status on T4 to T3 conversion in the anterior pituitary, animals were given 10 ug T4/100 g body wt per d for 5 d subcutaneously or were thyroidectomized 2-3 mo before the study (Table VI) . In T4-treated animals, the N: M ratio for T3(T3) was slightly but significantly reduced from that present in euthyroid control animals from the same group. An even greater reduction was observed in the N:M ratios for T3(T4), which were <50% of those observed in simultaneously studied controls. As a result, the value for R in T4-treated rat pituitaries was roughly half that obtained in euthyroid rats.
In chronically hypothyroid rats, the N:M ratios for both T3(T3) and T3(T4) were significantly higher than those in controls in the same experiment. The N:M ratio for T3(T3) was nearly twice that of normal animals, and the N:M ratio for T3(T4) was approximately five times that of the controls. The ratio R was increased two-to threefold over that in the euthyroid rats. When compared with the results for all the euthyroid controls (see above), the N:M for T3(T4) and R were also significantly greater in pituitaries from hypothyroid rats, P < 0.001 and P < 0.025, respectively. However, (8, (17) (18) (19) . The data in Table VII indicate that neither the N:M ratio for T3(T3) nor that for T3(T4) were significantly different from control after three night's fasting in 230-g rats. Hepatic T4 5'-monodeiodination was also quantitated in the same animals from which these anterior pituitaries were obtained (Table VII) . Hepatic T4 5'-monodeiodination was reduced to <50% of that in controls (P < 0.005). Effects of iopanoic acid, PTU, TRH and NaI on intrapituitary T4 to T3 conversion and nuclear binding. Iopanoic acid and PTU inhibit hepatic 5'-monodeiodination (8, (20) (21) (22) . Incubation of pituitary fragments with 13 ,uM iopanoic acid results in no alteration in the N:M ratio for T3(T3) but does result in a marked decrease in the N:M ratio for T3(T4) ( Table  VIII) Incubation with 29 ,uM PTU had no demonstrable effect on the N:M for T3(T3) and did not reduce the N:M T3(T4) ratio. As a result, R was not lower, and in one case it was statistically higher than in controls from the same pool of pituitary fragments. To investigate the possibility that in vivo treatment of animals with PTU might be required to inhibit T4 to T3 conversion, four normal animals were given 2 mg PTU/100 g body wt i.p. twice daily for 2 d before measuring body pituitary and hepatic T4 to T3 conversion. As is shown in Table VIII , there is no effect of PTU pretreatment Thyroxine to 3,5,3 '-Triiodothyronine Conversion in Anterior Pituitary on pituitary T4 to T3 conversion. In these same animals, the hepatic T4 5'-deiodination rate was reduced to 12% of the results in controls (P < 0.01, data not shown). Neither NaI (6 ,uM) nor TRH had a significant effect on the N:M T3(T3) or T3(T4) ratios. The concentrations of TRH used and the observed values for R were as follows: for 7 nM, R was 3.24+1.87 (mean+SE of triplicates); for 70 nM, R was 1.98+0.22; and for 700 nM, R was 3.33+0.38. The control value for R in this pool of euthyroid pituitaries was 3.81±0.51. might be theoretically desirable to determine the net [125I]T3 produced for each experiment, the data would have no more validity than is achieved more simply by the use of the R value which automatically corrects for any experimentally induced or endogenous differences in nuclear binding and for the modest losses in the isolation and identification of nuclear T3. It should be kept in mind that the extranuclear:medium T3 ratios were tested and found to be the same only for basal conditions and during incubations with 12.5 ng/ml T3 (Table I) It is presumably the small quantities of T3 generated that account for the failure of previous investigators using either tissue fragments (23) Data supporting the technical aspects of this method have been discussed (4, 7). Physiological substantiation is provided by the following aspects of the present report. Our previous in vivo experiments have shown that pretreatment of rats with amounts of PTU adequate to block _70% of total body T4 to T3 production neither decreased intrapituitary T4 to T3 conversion nor prevented the acute suppression of TSH release by T4 in chronically hypothyroid rats (2, 25). In the present studies, incubation of pituitary fragments with doses of PTU 10-fold higher than those that block hepatic T4 5'-monodeiodination did not affect intrapituitary T4 to T3 conversion (8) . Treatment of rats with quantities of PTU leading to 88% inhibition of T4 to T3 conversion in-livers subsequently studied in vitro also did not affect pituitary T4 to T3 conversion in the in vitro system. On the other hand, iopanoic acid-a potent inhibitor of hepatic T4 to T3 conversion (8)-can readily block pituitary T4 to T3 conversion, even suppressing the R ratio to unity in some experiments (Table VIII) . We have recently been able to demonstrate that iopanoic acid treatment of rats also blocks in vivo generation of T3 from T4 in the anterior pituitary and prevents the decrease in TSH associated with acute T4 administration (26) . Thus, with respect to both pharmacological agents, the response measured in this in vitro system is the same as that observed in vivo, and the physiological relevance of these results is supported.
There are, however, several aspects of the system which do not appear to be physiological. The data in Table II indicate that substantial quantities of [125I]T4 are nonspecifically bound to the nucleus, which is not the case in vivo (1-3) . This may be caused by the high concentrations of cytosolic [125I]T4 in the in vitro incubation system. Equilibrium is also not achieved in these studies, at least with respect to the N:M ratio for T3(T4) at 3 h (Table III) , although this does not appear to change the qualitative aspects of the results. About 16 h is required for equilibrium to be achieved in vivo between nuclear T3(T4) and plasma T4 in euthyroid rats (3). The estimated free T4 and T3 concentrations in the medium were 12 and 3 pg/ml at T4 and T3 concentrations of 3.8 and 0.14 ng/ml. The free hormone fractions obtained with this fraction V BSA preparation are lower than those usually obtained with crystalline BSA because it is a cruder preparation. The free fractions in the medium do not change at the T3 and T4 concentrations we have employed. Our studies in normal rats suggest that free T4 and T3 concentrations are about 15-25 and 1.1-2.0 pg/ml, respectively (27) . The data in Table V Effects of T3 and T4 on pituitary T4 monodeiodination and nuclear T3 binding. Since the nuclear T3 receptor binding capacity is limited, the observation (Table IV) that increasing concentrations of medium T3 decrease both the T3(T3) and T3(T4) N:M ratios is not surprising. That R does not change during this process indicates that the nuclear binding of T3(T3) and T3(T4) are equally affected by increases in tissue T3. This suggests that the two T3 pools, T3 from the medium and T3 from intrapituitary T4 generation, are completely miscible. This is consistent with our previous conclusions based on in vivo studies (2) and with the data in Table I . Secondly, the results also indicate that T3 itself does not inhibit T4 to T3 conversion in anterior pituitary tissue.
The maximum binding capacity for the pituitary nuclear T3 receptors can be roughly estimated from experiments C and D (Table IV) , taking non-specific binding into account. The result is 0.3-0.4 pg TJ4tg DNA, which is about 50% of the in vivo result (3, 28) . This difference may be a reflection of the failure to reach equilibrium, as well as of impaired tissue function under in vitro conditions. In vitro only 20% of the tissue T3 is bound to the nuclei, whereas in vivo this figure is -50% (28) .
The data in Table V show that with increasing medium T4 concentrations, the T3(T4) N:M ratio falls before that of T3(T3). This suggests that saturation of either the T4 5'-monodeiodination process or of tissue uptake of T4 has occurred. Because we have not found substantial differences in tissue [125I]T4 (as reflected by nuclear ['251]T4) with increasing medium T4 concentrations (Table II) , we suspect that it is the conversion mechanism that is saturated. The data are not consistent enough to allow accurate estimation of the T4 concentration at which saturation occurs, but it could be close to the physiological range for free T4. The lack of change in the N: M ratio for T3(T3) indicates that the depression of the N:M ratio for T3(T4) by T4 is not caused by saturation of nuclear receptors by T3 or T4.
Physiological alterations in anterior pituitary T45'-monodeiodination. Anterior pituitary 5'-monodeiodination appears to be markedly increased in hypothyroid rats. This is in contrast to hepatic T4 5'-monodeiodination, which is reduced under similar circumstances (16 Tables IV and V suggest that this cannot explain the phenomenon because pituitary T4 is only a small fraction of the T4 in the system. Both of these physiological observations, namely, stimulation of T4 5'-monodeiodination in hypothyroidism and its suppression in hyperthyroidism, have been observed by Kaplan in pituitary homogenates (34) .
A third physiological situation in which hepatic and pituitary T4 5'-monodeiodination differ is that of fasting. Hepatic T4 5'-monodeiodination in the rat is inhibited to about 50% ofcontrol during fasting (8, 19, 22) , whereas there appears to be no effect on pituitary 5'-monodeiodination in vitro (35) .2 It has been suggested that the suppression of hepatic T4 5'-monodeiodination in fasted rats is caused by depletion of a required cytosolic cofactor, probably GSH (19, 36, 37) . Thus, even though GSH concentrations are reportedly lower in pituitary than in liver (38) , depletion may occur less readily (37) . The In summary, these results extend our earlier in vivo studies and demonstrate clear effects of thyroid status and iopanoic acid on pituitary T4 to T3 conversion. The ability to study both T4 to T3 conversion and nuclear T3 binding simultaneously in vitro without the complex techniques and assumptions required for in vivo studies provides obvious advantages for the investigation of the variables involved in this process in this tissue. Qualitative differences are found in the regulation of T4 to T3 conversion in this organ when compared with the liver. These differences may have an important physiological role in TSH regulation. Because the thyrotroph is responsible for maintenance of the euthyroid state, it would be appropriate for this cell to be the most active of those in the pituitary with respect to T4 to T3 conversion. This is one conclusion that can be drawn from Table VI . Further studies will be required to resolve the uncertainties regarding the cellular regulation of T4 to T3 conversion in this unique tissue which appears to derive at least one-half of its nuclear T3 from local T4 5'-monodeiodination.
APPENDIX
The following results of a typical experiment are provided to allow the reader to assess the precision and accuracy of the primary data (4). The results are the mean±SD of the individual results of triplicate samples after a 3-h incubation of normal rat anterior pituitary fragments with 0.14 ng/ml medium T3 and 3.8 ng/ml medium T4. The medium volume is 400,d.
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